Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
19 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Dafiro“
Suchtreffer
Begriffe & Kennungen
Dafiro · 4.8 · % of patients who experienced peripheral Valsartan (mg) oedema 0 40 80 160 320 0 3.0 5.5 2.4 1.6 0.9 2.5 8.0 2
Eintrag öffnenDafiro · 4.8 · * Mostly consistent with cholestasis
Eintrag öffnenDafiro · 4.8 · 10 Skin and Dermatitis bullous -- -- Not known subcutaneous Erythema Uncommon -- -- tissue disorders Erythema
Eintrag öffnenDafiro · 4.8 · 11 Additional information on the combination
Eintrag öffnenDafiro · 4.8 · 12 Reporting of suspected adverse reactions
Eintrag öffnenDafiro · 4.8 · 9 Nervous system Coordination abnormal Uncommon -- -- disorders Dizziness Uncommon Common -- Dizziness postura
Eintrag öffnenDafiro · 4.8 · Additional information on the individual components
Eintrag öffnenDafiro · 4.8 · Adverse reactions have been ranked under headings of frequency using the following convention: very common (≥1
Eintrag öffnenDafiro · 4.8 · Adverse reactions previously reported with one of the individual components (amlodipine or valsartan) may be p
Eintrag öffnenDafiro · 4.8 · Amlodipine Common Somnolence, dizziness, palpitations, abdominal pain, nausea, ankle swelling. Uncommon Insomn
Eintrag öffnenDafiro · 4.8 · Exceptional cases of extrapyramidal syndrome have been reported.
Eintrag öffnenDafiro · 4.8 · MedDRA Adverse reactions Frequency System organ Dafiro Amlodipine Valsartan class Infections and Nasopharyngit
Eintrag öffnenDafiro · 4.8 · Peripheral oedema, a recognised side effect of amlodipine, was generally observed at a lower incidence in pati
Eintrag öffnenDafiro · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenDafiro · 4.8 · Summary of the safety profile
Eintrag öffnenDafiro · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenDafiro · 4.8 · The mean incidence of peripheral oedema evenly weighted across all doses was 5.1% with the amlodipine/valsarta
Eintrag öffnenDafiro · 4.8 · The safety of Dafiro has been evaluated in five controlled clinical studies with 5,175 patients, 2,613 of whom
Eintrag öffnenDafiro · 4.8 · Valsartan Not known Decrease in haemoglobin, decrease in haematocrit, neutropenia, thrombocytopenia, increase
Eintrag öffnen